Skip to main content
. 2017 Aug 24;7:9373. doi: 10.1038/s41598-017-09668-2

Figure 1.

Figure 1

Combination of NCTD and CLSO significantly inhibits cell viability in HepG2 and HepG2/ADM cells. (a) The percentage of viable cells as measured by the MTT assay at 24 and 48 h relative to no-drug controls and NCTD concentrations were plotted as a dose response curve (n = 6 per group). (b) Cells treated with the CLSO(n = 6 per group). (c) Cells treated with the combination of NCTD and CLSO. Cell viability was assayed (n = 6 per group). (d) Cytotoxicity of bare microemulsion formulation (containing Span-80 1 g and Sween-80 1.5 g) against HepG2 and HepG2/ADM cells. *P < 0.05; **P < 0.01, vs. control, aP < 0.05; aaP < 0.01 vs. NCTD alone, bP < 0.05; bbP < 0.01 vs. CLSO alone. One-way ANOVA, post hoc comparisons, Tukey’s test. Columns, means; error bars, SDs.